FDA oversight of clinical trials is "grossly inadequate," say experts

BMJ. 2022 Nov 16:379:o2628. doi: 10.1136/bmj.o2628.
No abstract available

MeSH terms

  • Clinical Trials as Topic*
  • Humans
  • United States
  • United States Food and Drug Administration*